JP2024527142A5 - - Google Patents
Info
- Publication number
- JP2024527142A5 JP2024527142A5 JP2024506585A JP2024506585A JP2024527142A5 JP 2024527142 A5 JP2024527142 A5 JP 2024527142A5 JP 2024506585 A JP2024506585 A JP 2024506585A JP 2024506585 A JP2024506585 A JP 2024506585A JP 2024527142 A5 JP2024527142 A5 JP 2024527142A5
- Authority
- JP
- Japan
- Prior art keywords
- mutation
- dna
- group
- tumor
- length threshold
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21189685.7A EP4130293A1 (en) | 2021-08-04 | 2021-08-04 | Method of mutation detection in a liquid biopsy |
| EP21189685.7 | 2021-08-04 | ||
| PCT/EP2022/071749 WO2023012186A1 (en) | 2021-08-04 | 2022-08-02 | Method of mutation detection in a liquid biopsy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527142A JP2024527142A (ja) | 2024-07-19 |
| JP2024527142A5 true JP2024527142A5 (cg-RX-API-DMAC7.html) | 2025-08-06 |
Family
ID=77226600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506585A Pending JP2024527142A (ja) | 2021-08-04 | 2022-08-02 | リキッドバイオプシーにおける変異検出の方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240327924A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4130293A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024527142A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023012186A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120048346B (zh) * | 2025-01-24 | 2026-02-27 | 中科金辰生物科技(合肥)有限公司 | 一种肿瘤特异性基因突变和甲基化联合生物信息学分析方法及系统 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3256605T3 (da) * | 2015-02-10 | 2022-03-14 | Univ Hong Kong Chinese | Påvisning af mutationer til cancerscreening og føtal analyse |
| US11342047B2 (en) | 2017-04-21 | 2022-05-24 | Illumina, Inc. | Using cell-free DNA fragment size to detect tumor-associated variant |
| EP3762512A1 (en) * | 2018-03-06 | 2021-01-13 | Cancer Research Technology Limited | Improvements in variant detection |
| GB201819134D0 (en) * | 2018-11-23 | 2019-01-09 | Cancer Research Tech Ltd | Improvements in variant detection |
| GB201818159D0 (en) | 2018-11-07 | 2018-12-19 | Cancer Research Tech Ltd | Enhanced detection of target dna by fragment size analysis |
| US11929148B2 (en) | 2019-03-13 | 2024-03-12 | Grail, Llc | Systems and methods for enriching for cancer-derived fragments using fragment size |
| AU2020364225B2 (en) * | 2019-10-08 | 2023-10-19 | Illumina, Inc. | Fragment size characterization of cell-free DNA mutations from clonal hematopoiesis |
-
2021
- 2021-08-04 EP EP21189685.7A patent/EP4130293A1/en not_active Withdrawn
-
2022
- 2022-08-02 EP EP22758542.9A patent/EP4381092A1/en active Pending
- 2022-08-02 JP JP2024506585A patent/JP2024527142A/ja active Pending
- 2022-08-02 WO PCT/EP2022/071749 patent/WO2023012186A1/en not_active Ceased
- 2022-08-02 US US18/293,951 patent/US20240327924A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Addeo et al. | TMB or not TMB as a biomarker: That is the question | |
| KR102930361B1 (ko) | 암의 평가 및/또는 치료를 위한 무 세포 dna | |
| CN114736968B (zh) | 血浆游离dna甲基化标志物在肺癌早筛中的用途以及肺癌早筛装置 | |
| CN110689921B (zh) | 微卫星不稳定性检测装置、计算机设备及计算机存储介质 | |
| RU2760577C2 (ru) | Способы прогнозирования рака предстательной железы | |
| JP7634714B2 (ja) | 人工知能基盤の無細胞DNAの腫瘍由来変異の検出方法及びこれを用いたがんの早期診断方法{Method for detecting tumor derived mutation from cell-free DNA based on artificial intelligence and Method for early diagnosis of cancer using the same} | |
| JP2021503149A (ja) | がん治療の有効性を予測するためのシステムおよび方法 | |
| TWI670495B (zh) | 一種鑑定樣本中腫瘤負荷的方法和系統 | |
| JP2023508947A5 (cg-RX-API-DMAC7.html) | ||
| WO2015035415A1 (en) | Method of detecting suceptibility to breast cancer through mutations in the fgfr3 and tp53 genes | |
| JP2023082157A (ja) | 遺伝子調節 | |
| CN111899789B (zh) | 二代测序鉴定brca1/2大片段重排的方法及系统 | |
| JP2021523744A (ja) | 脳卒中の血液バイオマーカー | |
| CN116762132A (zh) | 基于游离dna的疾病预测模型及其构建方法和应用 | |
| KR20170067137A (ko) | 암 진단용 miRNA 바이오마커 발굴 방법 및 그 이용 | |
| CN119776488A (zh) | 一种心力衰竭的生物标志物及其应用 | |
| KR20240015624A (ko) | 게놈 전체 cfdna 단편화 프로파일을 이용한 암을 검출하는 방법 | |
| JP6784673B2 (ja) | 膵臓がんに冒された患者の生存予後を判断する方法 | |
| CN111172285A (zh) | 用于胰腺癌早期诊断和/或预后监测的miRNA组及其应用 | |
| CN110004229A (zh) | 多基因作为egfr单克隆抗体类药物耐药标志物的应用 | |
| JP2024504062A (ja) | 染色体相互作用 | |
| US20250101522A1 (en) | Brca1 promoter methylation in sporadic breast cancer patients detected by liquid biopsy | |
| US20190352704A1 (en) | Benign thyroid nodule-specific gene | |
| WO2025019254A1 (en) | Classification of breast tumors using dna methylation from liquid biopsy | |
| JP2017079730A (ja) | 関節リウマチに対する生物学的製剤の治療効果を予測する方法、およびそれを用いて最適な薬剤を選択する方法 |